openPR Logo
Press release

Neurodegenerative Diseases Drugs Market set for rapid growth forecst 2020-2026| Key Players: Biogen Pfizer, Inc., F. Hoffmann-La Roche Ltd, Merck & Co., Inc., Novartis AG, Sanofi, Teva Pharmaceutical Industries Ltd., Orion Pharma, UCB S.A, ACADIA Pharmace

04-22-2020 05:36 PM CET | Health & Medicine

Press release from: Fortune Business Insights Pvt. Ltd.

Neurodegenerative Diseases Drugs Market set for rapid growth

The global neurodegenerative diseases drugs market's growth is expected to derive growth from the rising prevalence of neurodegenerative diseases especially among the aging population. Fortune Business Insights in a report, titled "Neurodegenerative Diseases Drugs: Global Market Analysis, Insights and Forecast, 2019-2026" offers valuable insights into the trends prevailing in the market. In 2018, the global market was valued at US$35,497.3 Mn and is projected to be worth US$ 62,786.2 Mn by 2026. At this pace, the global market is estimated to exhibit a healthy CAGR of 7.2% during the forecast duration.
Request a Sample Copy of the Research Report: https://www.fortunebusinessinsights.com/enquiry/request-sample-pdf/neurodegenerative-diseases-drugs-market-100661
Key Companies and Manufacturers Covered:
o Biogen
o Pfizer, Inc.
o F. Hoffmann-La Roche Ltd
o Merck & Co., Inc.
o Novartis AG
o Sanofi
o Teva Pharmaceutical Industries Ltd.
o Orion Pharma
o UCB S.A
o ACADIA Pharmaceuticals Inc.
o H. Lundbeck A/S
o Mitsubishi Tanabe Pharma Corporation

The emergence of COVID-19 has brought the world to a standstill. We understand that this health crisis has brought an unprecedented impact on businesses across industries. However, this too shall pass. Rising support from governments and several companies can help in the fight against this highly contagious disease. There are some industries that are struggling and some are thriving. Overall, almost every sector is anticipated to be impacted by the pandemic.
We are taking continuous efforts to help your business sustain and grow during COVID-19 pandemics. Based on our experience and expertise, we will offer you an impact analysis of coronavirus outbreak across industries to help you prepare for the future.
Click here to get the short-term and long-term impact of COVID-19 on this Neurodegenerative Diseases Drugs Market.
Please visit: https://www.fortunebusinessinsights.com/industry-reports/neurodegenerative-diseases-drugs-market-100661
Key Features of Neurodegenerative Diseases Drugs Market Report:
o Overview, Industry Life Cycle Analysis, Supply Chain Analysis
o Size, Trends, Growth Drivers, Constraints, SWOT Analysis, Forecast Analysis
o Competitive Landscapes: Market Share, Product Portfolio, New Product Launches, etc.
o Market attractiveness and Associated Growth Opportunities
o Strategic Growth Opportunities for the Existing and New Players
o Key Success Factors

Biogen's Strategic Initiatives Helps the Company to Earn More Profits
In the year 2018, Biogen was dominating the global market. Neurodegenerative disease drug discovery and some important strategic decisions help the company to gain more attention. The launch of a drug called SPINRAZA and increasing sales of another drug called Tecfidera in 2018 helped the company to strengthen its product portfolio. Also, the company entered into a strategic partnership with F. Hoffmann-La Roche Ltd. to ensure robust distribution of drugs. This, together with the launch of two new drugs called Madopar and Ocrevus helped F. Hoffmann-La Roche Ltd. to gain the second position in the market.

Have Any Query? Ask Our Experts: https://www.fortunebusinessinsights.com/enquiry/speak-to-analyst/neurodegenerative-diseases-drugs-market-100661

Reasons to Purchase this Report:

o Detailed business profiles including product offerings, recent developments, key financial information, and strategies employed by main market players.
o Analysis of various regions and countries that includes the demand and supply based actions, which consequently have a major influence on the market's expansion.
o Market dynamics and opportunities for growth for players in the near future.
o Competitive landscape describing the market revenue shares of key players.
o Market segmentation analysis that deals with quantitative and qualitative research, discussing the influence of policy-based and economical aspects.

About Us:

Fortune Business Insights(TM) offers expert corporate analysis and accurate data, helping organizations of all sizes make timely decisions. We tailor innovative solutions for our clients, assisting them to address challenges distinct to their businesses. Our goal is to empower our clients with holistic market intelligence, giving a granular overview of the market they are operating in.

Our reports contain a unique mix of tangible insights and qualitative analysis to help companies achieve sustainable growth. Our team of experienced analysts and consultants use industry-leading research tools and techniques to compile comprehensive market studies, interspersed with relevant data.

Contact Us:
Fortune Business Insights(TM) Pvt. Ltd.
308, Supreme Headquarters,
Survey No. 36, Baner,
Pune-Bangalore Highway,
Pune - 411045, Maharashtra, India.

Phone:
US :+1 424 253 0390
UK : +44 2071 939123
APAC : +91 744 740 1245

Email: sales@fortunebusinessinsights.com

Linkedin | Twitter | BLogs

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Neurodegenerative Diseases Drugs Market set for rapid growth forecst 2020-2026| Key Players: Biogen Pfizer, Inc., F. Hoffmann-La Roche Ltd, Merck & Co., Inc., Novartis AG, Sanofi, Teva Pharmaceutical Industries Ltd., Orion Pharma, UCB S.A, ACADIA Pharmace here

News-ID: 2021018 • Views:

More Releases from Fortune Business Insights Pvt. Ltd.

Luxury Goods Market Size Report, Trends, Overview, Outlook & Future Growth By 2030
Luxury Goods Market Size Report, Trends, Overview, Outlook & Future Growth By 20 …
The global luxury goods market size was valued at USD 272.74 billion in 2022. The market is anticipated to grow from USD 284.00 billion in 2023 to USD 392.40 billion by 2030, exhibiting a CAGR of 4.7% during the forecast period. Luxury products signify the status symbol of an individual. Businesses focus on high-income populations with visually appealing designs and technology-integrated products. For instance, NFC-installed chips in jewelry; a product called
With 17.2% CAGR, Smart Glass market Market to Hit USD 15,788.0 Million by 2022-2027 | Key Companies Profiled: BSG Glass, NSG Groupe, Schott AG
With 17.2% CAGR, Smart Glass market Market to Hit USD 15,788.0 Million by 2022-2 …
The global smart glass market size is anticipated to reach USD 15,788.0 million by 2027, owing to the rise in the use of smart glass for different applications such as aerospace, marine, architectural, and automotive. Smart glass or switchable glass is glazing or a glass with altered transmission properties as and when heat, light, or voltage is applied. They are capable of changing their appearance from opaque to translucent to transparent
Non-alcoholic Beverages Market Segmentation& Analysis, Industry Growth Forecast 2020-2027
Non-alcoholic Beverages Market Segmentation& Analysis, Industry Growth Forecast …
According to Fortune Business Insights ™, the global non-alcoholic beverages market size is anticipated to rise significantly on account of the current trend of health and fitness and the rising inclination towards healthy beverages. The value of this market was USD 919.13 billion in 2019 and is expected to rise at a CAGR of 8.20% between 2020 to 2027 to reach USD 1,257.77 billion by the end of 2027. List of
Intravenous Iron Drugs Market 2022: Global Technology, Segmentation, Growth, Development, Trends and Forecasts to 2027
Intravenous Iron Drugs Market 2022: Global Technology, Segmentation, Growth, Dev …
Global Intravenous Iron Drugs Market Size research report 2022 offers an in-depth assessment of revenue growth, market definition, segmentation, industry potential, influential trends for understanding the future outlook and current prospects for the market. The demand for refractive surgeries is anticipated to increase, attributed to the rise in the aging population and excessive use of digital devices, which has increased the screen time of the world population due to the

All 5 Releases


More Releases for Neurodegenerative

03-05-2018 | Science & Education
PR&D
Clinical Results of Neurodegenerative Study
AFFiRiS Announces Results of a Phase I Clinical Study Using AFFITOPEs® PD01A and PD03A, Confirming Safety and Tolerability for Both Compounds as well as Immunogenicity for PD01A in Early MSA patients • AFFITOPEs® PD01A and PD03A Safe and Well Tolerated: Primary Endpoint of Phase I Study Met • Immune Response against AFFITOPE® PD01A and Alpha-Synuclein Seen in Patients with Early Multiple System Atrophy (MSA), an Orphan Disease • Prof. Wassilios Meissner, Principal Investigator of the Study
Neurodegenerative Disorders Drug Development Pipeline Review, 2017
"Neurodegenerative Disorders Drug Development Pipeline Review, 2017" The Report covers current Industries Trends, Worldwide Analysis, Global Forecast, Review, Share, Size, Growth, Effect. . . Description- '
Neurodegenerative Disorders Drug Development Pipeline Review, 2017
"Neurodegenerative Disorders Drug Development Pipeline Review, 2017" The Report covers current Industries Trends, Worldwide Analysis, Global Forecast, Review, Share, Size, Growth, Effect. Description- Neurodegenerative disorders are a cluster of conditions that affect the central nervous system. They include both hereditary and sporadic conditions that are characterized by slow, irreversible, progressive dysfunction of the nervous system with the increasing degeneration of neurons, which causes symptoms such as motor impairment, memory loss and declining
Neurodegenerative Disorders Drug Development Pipeline Review, 2017
ReportsWorldwide has announced the addition of a new report title Neurodegenerative Disorders Drug Development Pipeline Review, 2017 to its growing collection of premium market research reports. Neurodegenerative disorders are a cluster of conditions that affect the central nervous system. They include both hereditary and sporadic conditions that are characterized by slow, irreversible, progressive dysfunction of the nervous system with the increasing degeneration of neurons, which causes symptoms such as motor impairment,
Growing Incidences of Neurodegenerative Conditions to Boost Market Growth for Ne …
"The Report Global Neurodegenerative Drugs Market to 2022 - Growth Driven by an Aging Population, the Approval of Novel Immunomodulators and Neuromodulators, and Strong Uptake of Marketed Anti-Inflammatory Treatments provides information on pricing, market analysis, shares, forecast, and company profiles for key industry participants. - MarketResearchReports.biz" MarketResearchReports.biz has announced the addition of a new market research report to its report repository. The publication is titled, “Global Neurodegenerative Drugs Market To
Global Neurodegenerative Diseases Consumption 2016 Market Research Report
ReportBazzar has announced a new report titled "Global Neurodegenerative Diseases Consumption 2016 Market Research Report" To their offerings Browse Report Summary with TOC: http://www.reportbazzar.com/product/global-neurodegenerative-diseases-consumption-2016-market-research-report/ The Global Neurodegenerative Diseases Consumption 2016 Market Research Report is a professional and in-depth study on the current state of the Neurodegenerative Diseases market. First, the report provides a basic overview of the Neurodegenerative Diseases industry including definitions, classifications, applications and industry chain structure. And development policies and plans